Medical Press Release - Page 5 of 12 - Medika Life : Keeping you informed

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life - August 6, 2020

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

A New A.I. Based Solution to Nurse Burn-out and Turnover

Medika Life - September 16, 2020

What can we do to ensure that those we rely upon to care for us, are being supported in this essential, important work?

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life - February 27, 2024

Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

The 50 Most Influential Leaders in Pharmacy 2022 Awards

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Children with no COVID-19 symptoms may shed virus for weeks

South University Announces New MSPA Program at West Palm Beach Campus

EDITORS CHOICE

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

A New A.I. Based Solution to Nurse Burn-out and Turnover

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories